EU secures four million additional doses of Pfizer-BioNTech vaccine

By Brian Buntz | March 11, 2021

The European Commission has announced that it has secured four million more COVID-19 vaccine doses than it had expected to be delivered over the next two weeks.

The vaccines will help E.U. “tackle coronavirus hotspots,” “facilitate free border movement” and fight COVID-19 variants.

The E.U. has been involved in a recent vaccine-related tussle with the U.K., with European Council President Charles Michel accusing the U.K. of blocking vaccine exports to the Continent. U.K. Prime Minister Boris Johnson has refuted that claim.

The U.K. has outpaced the E.U. in vaccine administration, having administered vaccines to more than a third of its population while the E.U. has done so for 9.5%.

Several regions in Europe have seen infection rates and hospitalizations tick up recently, including Tyrol in Austria, Nice and Moselle in France, Bolzano in Italy and some parts of Bavaria and Saxony in Germany.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.